Considering the facts that these inflammatory cytokines are described for both animal models of colitis [27] and human IBD [28], it is possible to predict that decreased level and/or activity of TTP in ulcerative colitis patients may lead to a defect in resolution of intestinal inflammation and exacerbated IBD symptoms. This evidence concerns the gene ZFP36 and ulcerative colitis.